Is Descovy really the better option?
When the FDA approved Gilead’s Truvada (emtricitabine/tenofovir disoproxil) for HIV PrEP in 2012, it was a revolutionary step forward. The drug was safe and up to 99 percent effective in preventing HIV infection in at-risk individuals.
Then in 2019, Gilead received FDA approval for a second drug for PrEP called Descovy (emtricitabine/tenofovir alafenamide), with equivalent efficacy to Truvada. Recent research has shown that by the end of 2020, …
Is Descovy really the better option?






![Clinicians are failing at value-based care because no one taught them the system [PODCAST]](https://kevinmd.com/wp-content/uploads/bd31ce43-6fb7-4665-a30e-ee0a6b592f4c-190x100.jpeg)











![Why cervical cancer screening drops after menopause, and why that’s dangerous [PODCAST]](https://kevinmd.com/wp-content/uploads/Gemini_Generated_Image_h8guhqh8guhqh8gu-190x100.png)


